0001209191-17-036273.txt : 20170530
0001209191-17-036273.hdr.sgml : 20170530
20170530190902
ACCESSION NUMBER: 0001209191-17-036273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170525
FILED AS OF DATE: 20170530
DATE AS OF CHANGE: 20170530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCKINNELL HENRY A
CENTRAL INDEX KEY: 0001174453
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 17879093
MAIL ADDRESS:
STREET 1: 7 WORLD TRADE CENTER
STREET 2: 250 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-25
0
0001340652
ChemoCentryx, Inc.
CCXI
0001174453
MCKINNELL HENRY A
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2017-05-25
4
A
0
12912
0.00
A
44218
D
The restricted stock was awarded on May 25, 2017, and 100% of the restricted stock will vest on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2017-05-30